Filter Results:
(298)
Show Results For
- All HBS Web
(298)
- People (1)
- News (81)
- Research (187)
- Multimedia (4)
- Faculty Publications (124)
Show Results For
- All HBS Web
(298)
- People (1)
- News (81)
- Research (187)
- Multimedia (4)
- Faculty Publications (124)
- December 2012
- Teaching Note
Gene Patents (A) (TN)
By: Richard G. Hamermesh and Matthew Preble
This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details
- October – December 1998
- Article
The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA Typing Companies
By: Arthur A. Daemmrich
Daemmrich, Arthur A. "The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA Typing Companies." Special Issue on Contested Identities: Science, Law and Forensic Practice. Social Studies of Science 28, nos. 5/6 (October–December 1998): 741–772.
- 1997
- Chapter
Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond
By: Josh Lerner and Robert P. Merges
Keywords: Patents; Applications and Software; Genetics; Information Technology Industry; Biotechnology Industry
Lerner, Josh, and Robert P. Merges. "Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond." In Competing in the Age of Digital Convergence, edited by D. B. Yoffie, 301–324. Boston: Harvard Business School Press, 1997.
- Web
Teams | New Venture Competition
Teams Business Track Winners, 2024 Crop Diagnostix Brandon Chi (MBA 2024) Joseph Swift, Amitesh Pratap Business Track Winner Redefining precision agriculture through AI-powered, genetic insights. Sanso Narek Dshkhunyan (MBA 2024) Daniel... View Details
- 01 Sep 2008
- News
Mara Aspinall
1,500-person division is a leader in the emerging field of personalized medicine, which treats cancer and other diseases with customized therapies that take into account the patient’s specific genetic traits. With HBS professor Richard... View Details
- September 2000
- Case
Novartis Agricultural Discovery Institute (A)
Steve Briggs, a PhD biologist, is asked to propose a strategy to take global life-science giant Novartis into the rapidly expanding field of plant genomics. View Details
Keywords: Design; Plant-Based Agribusiness; Genetics; Infrastructure; Biotechnology Industry; Agriculture and Agribusiness Industry
West, Jonathan, and Christian G. Kasper. "Novartis Agricultural Discovery Institute (A)." Harvard Business School Case 601-010, September 2000.
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
cells in cancer patients) generated more than $2 billion in sales last year. Millennium Pharmaceuticals: Alan Crane (photo: Shelly R. Harrison) As the ability to analyze a patient's genetic material is developed, however, many believe... View Details
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's View Details
Keywords: Julia Hanna
- June 2003 (Revised March 2008)
- Case
Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene
By: Regina E. Herzlinger and Marc Aquino
Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details
Keywords: Health Disorders; Research and Development; Genetics; Biotechnology Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Marc Aquino. "Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene." Harvard Business School Case 303-044, June 2003. (Revised March 2008.)
- 27 Jul 2022
- News
Alumna-Led Reproductive Health Startup Raises $4.7 Million
Thain Gioia and her cofounder realizing there were serious deficits in the information offered during their pregnancies. “Personally, my daughter was born with a cleft lip—though I had no risk factors or genetic link—it really knocked me... View Details
- 01 Aug 2001
- News
Ray A. Goldberg (MBA '50)
companies and countries worldwide and, before retiring in 1997, had taught some seven thousand Harvard MBA students and ten thousand Executive Education participants. Most recently, Goldberg has focused on the impact that advances in View Details
- 25 Jul 2011
- Research & Ideas
How Disruptive Innovation is Remaking the University
against the same criteria applied to his or her predecessor. The way things are done is determined not by individual preference but by institutional procedure written into the genetic code. There is evolution in the university, though its... View Details
- 01 Dec 2010
- News
You Are What You Eat
Writing in the magazine Pig Progress (September 23, 2010), Austria-based John Hodges (AMP 52, 1967),an expert on genetics and ethics in agriculture, food, and the environment, warned that the current system of agribusiness is untenable.... View Details
- November 1999
- Case
E.I. du Pont de Nemours and Company (B)
DuPont must decide whether to launch a new non-GM (genetically modified) soybean that is tolerant to chemical sprays. In the face of rapid introductions of GM products by competitors, DuPont faces the challenge of ensuring the identity preservation of its new product... View Details
Keywords: Business Model; Customer Value and Value Chain; Genetics; Agriculture and Agribusiness Industry
West, Jonathan, and Christian G. Kasper. "E.I. du Pont de Nemours and Company (B)." Harvard Business School Case 600-051, November 1999.
- February 2008 (Revised August 2008)
- Case
EXACT Sciences Corp.: Commercializing a Diagnostic Test
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details
Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
- 10 Dec 2010
- News
Notes from the Trenches
Executive Director Mike Roberts, the lineup lost no time in getting down to brass tacks with the SRO student crowd of would-be entrepreneurs. Paris Wallace (MBA ’07) of Good Start Genetics noted that the BPC is an effective way to meet... View Details
- Web
Timeline - Race, Gender & Equity
bankruptcy or bad debts 1985 USDA approves the sale of the first genetically altered organism 1986 Immigration Reform and Control Act prohibits employers with more than three employees from discriminating against anyone (except... View Details
- 24 Apr 2014
- News
Founding a bone marrow donor bank that saves thousands of lives
in the world, helping thousands of patients with leukemia and other life-threatening diseases in need of matching donors to save their lives. Because a close genetic match is necessary, even with a registry of millions, 6 out of 10... View Details
- 06 Sep 2016
- News
Connecting Past and Present
Family health was the impetus for Stanley Diamond (MBA 1958), founder of one of the world’s largest genealogy resources. “My family carries the beta thalassemia genetic trait,” a blood disorder. When my nephew was diagnosed, and we then... View Details
- 16 Mar 2015
- News
A Sustainable Approach to Physics Education
Ogden, who grew up in a working-class family, recalls the power of his own education, leading up to his time at HBS, where the idea of paying it forward was part of the School’s DNA. “There’s something in the genetic code of the School... View Details